Ginkgo Bioworks Holdings, Inc. (DNA) Stock Overview
NYSE · Healthcare · Biotechnology
✓ Sourced directly from Yahoo Finance · Checked for accuracy at every rebuild · Snapshot: 6 September 2026
About Ginkgo Bioworks Holdings, Inc.
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops a platform for cell engineering in the United States. It operates through the Cell Engineering and Biosecurity segments. The company offers cell engineering research and development solutions, as well as cell engineering…
Source: Yahoo Finance
Sector & Industry
Ginkgo Bioworks Holdings, Inc. operates in the Healthcare sector, within the Biotechnology industry group. It is listed on the NYSE exchange.
Ginkgo Bioworks Holdings, Inc. at a Glance
| Company | Ginkgo Bioworks Holdings, Inc. |
| Ticker | DNA |
| Exchange | NYSE |
| Currency | USD |
| Price | $6.95 |
| Market cap | $468.01M |
| P/E ratio (trailing) | — |
| EPS (trailing) | -$5.33 |
| 52-week high | $17.58 |
| 52-week low | $5.37 |
| Dividend yield | — |
| Ex-dividend date | — |
| Beta | 1.77 |
| Return on equity (ROE) | -59.94% |
| Debt-to-equity | 96.15% |
| Average volume | 1.11M |
| Shares outstanding | 55.38M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Employees | 485 |
| Country | United States |
Investing Essentials
As an Amazon Associate we earn from qualifying purchases. Links below are affiliate links.
Peter Lynch on how everyday investors can spot winners before the professionals do.
Check Price →Evaluating pharma pipelines, devices and healthcare economics.
Check Price →Benjamin Graham's classic on value investing — the book Warren Buffett calls the best ever written on the subject.
Check Price →Frequently Asked Questions
- What is Ginkgo Bioworks Holdings, Inc.'s current P/E ratio?
- Ginkgo Bioworks Holdings, Inc. (DNA) has a trailing P/E ratio of — as of our 6 September 2026 data snapshot. Learn what the P/E ratio means →
- What is Ginkgo Bioworks Holdings, Inc.'s market capitalisation?
- Ginkgo Bioworks Holdings, Inc.'s market cap is $468.01M based on our latest snapshot. See how it ranks by market cap →
- What is DNA's 52-week range?
- Over the past 52 weeks, DNA has traded between $5.37 and $17.58. What does the 52-week range mean? →
- How volatile is Ginkgo Bioworks Holdings, Inc. compared to the market?
- Ginkgo Bioworks Holdings, Inc. has a beta of 1.77, meaning it has historically moved more than the broader market. What does beta measure? →
- Does Ginkgo Bioworks Holdings, Inc. pay a dividend?
- Ginkgo Bioworks Holdings, Inc. does not currently pay a dividend according to our latest data.
- What exchange is DNA listed on?
- DNA is listed on the NYSE. Browse all NYSE-listed stocks →
- What sector is Ginkgo Bioworks Holdings, Inc. in?
- Ginkgo Bioworks Holdings, Inc. is classified in the Healthcare sector. Compare with Healthcare peers →
Working out potential returns or position sizes? Our payout and odds calculators handle the maths.
Many readers keep a stock investing journal to log positions and theses alongside pages like this one, and a dedicated financial calculator to hand for quick valuation maths.
Recommended Reading & Tools
Morgan Housel's short lessons on behaviour, luck and long-term wealth.
Check Price →Philip Fisher on what makes a business worth owning for the long term.
Check Price →Burton Malkiel's evidence-based guide to markets, indexing and long-term strategy.
Check Price →